Avi Rosenbaum,

Avi Abraham Rosenbaum is a biotech strategist and investor at the forefront of transformative ventures in the life sciences. He is the founder of advisors.bio, providing strategic guidance in company formation, technology assessment, fundraising, and team building within the biotech and pharmaceutical sectors.

As Chief Operating Officer at Peak B Bio, Avi co-managed operations for a pioneering synthetic biology company, driving strategic positioning, financial modeling, and M&A activities. His consultancy experience also includes advising public market biotech and pharma hedge funds with a combined AUM exceeding $8 billion, and serving as a Venture Partner on investments including Mammoth Biosciences and Shape Therapeutics.

Previously, Avi led an R&D team at Thermo Fisher Scientific, contributing to the development and launch of eleven commercial products for personalized medicine, diagnostics, and research markets. He holds a Ph.D. in Genetics from Harvard University under George Church, is the inventor on five patents, and co-author of widely cited academic publications with over 2,500 citations.